Despite the prevalence of dry eye disease it remains a mystery as to what exactly causes this condition. However, recent research has made strides in understanding it.
Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy.
A small clinical trial demonstrates encouraging early results using an adopted version of CAR T therapy to treat patients with rare autoimmune disorder myasthenia gravis.
A recent study by revealed a link between bacterial blooms of the gut bacterium Ruminococcus blautia gnavus and flare-ups of disease in women with Lupus Nephritis.
A drug called bulevirtide marks the first treatment option available to hepatitis D patients since the discovery of the virus in 1977. Real-world results are promising.
A recent paper brings us closer to creating an accurate model of the lungs. This progress may lead to a deeper understanding of lung diseases and how they can be treated.